The prevalence of opioid use during pregnancy is increasing. Two downstream effects are neonatal abstinence syndrome (NAS), a postnatal withdrawal syndrome, and long-term prenatal opioid exposure (LTPOE) without documented withdrawal symptoms in the infant. Mental health characteristics of mothers of infants with NAS and LTPOE have not been described.
Using linked maternal and infant Medicaid claims and birth certificate data, we analyzed 15,571 infants born to Medicaid-insured women 15–24 years old in a mid-Atlantic city from 2007 to 2010. Pairwise comparisons with multinomial logistic regression, adjusting for maternal and infant covariates, were performed. We compared four mental health conditions among mothers of infants with NAS, infants with LTPOE without NAS, and controls: depression, anxiety, bipolar disorder, and schizophrenia.
The prevalence of depression among mothers of infants with NAS, infants with LTPOE, and controls was 26, 21.1, and 5.5% respectively. Similar results were found for anxiety. In multivariable analysis, mothers of infants with NAS and LTPOE had approximately twice the depression risk as controls, while mothers of infants with LTPOE had 2.2 times the bipolar disorder risk and 4.6 times the schizophrenia risk as controls. The overall risk of mental health conditions in mothers of infants with NAS and LTPOE was similar.
Mothers of infants with LTPOE who did not develop NAS are at similarly high risk for mental health conditions as mothers of infants with NAS, and both are at higher risk than controls. Therefore, those mothers of infants who did not develop symptoms of NAS despite LTPOE may be a vulnerable population that needs additional mental health support in the post-partum period.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Bateman, B. T., Hernandez-Diaz, S., Rathmell, J. P., et al. (2014). Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology, 120(5), 1216–1224. https://doi.org/10.1097/ALN.0000000000000172.
Burns, K., Melamed, J., Burns, W., Chasnoff, I., & Hatcher, R. (1985). Chemical dependence and clinical depression in pregnancy. Journal of Clinical Psychology, 41(6), 851–854.
Cabrera, N. J., Ryan, R. M., Mitchell, S. J., Shannon, J. D., & Tamis-Lemonda, C. S. (2008). Low-income, nonresident father involvement with their toddlers: Variation by fathers’ race and ethnicity. Journal of Family Psychology, 22(4), 643–647. https://doi.org/10.1037/0893-3220.127.116.113.
Desai, R. J., Hernandez-Diaz, S., Bateman, B. T., & Huybrechts, K. F. (2014). Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics and Gynecology, 123(5), 997–1002. https://doi.org/10.1097/AOG.0000000000000208.
Desai, R. J., Huybrechts, K. F., Hernandez-Diaz, S., et al. (2015). Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: Population based cohort study. BMJ, 350, h2102. https://doi.org/10.1136/bmj.h2102.
Dryden, C., Young, D., Hepburn, M., & MacTier, H. (2009). Maternal methadone use in pregnancy: Factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG: An International Journal of Obstetrics and Gynaecology, 116(5), 665–671. https://doi.org/10.1111/j.1471-0528.2008.02073.x.
Epstein, R. A., Bobo, W. V., Martin, P. R., et al. (2013). Increasing pregnancy-related use of prescribed opioid analgesics. Annals of Epidemiology, 23(8), 498–503. https://doi.org/10.1016/j.annepidem.2013.05.017.
Fitzsimons, H. E., Tuten, M., Vaidya, V., & Jones, H. E. (2007). Mood disorders affect drug treatment success of drug-dependent pregnant women. Journal of Substance Abuse Treatment, 32(1), 19–25. https://doi.org/10.1016/j.jsat.2006.06.015.
Haller, D. L., Knisely, J. S., Dawson, K. S., & Schnoll, S. H. (1993). Perinatal substance abusers. Psychological and social characteristics. Journal of Nervous and Mental Disease, 181(8), 509–513. https://doi.org/10.1097/00005053-199308000-00006.
Holbrook, A., & Kaltenbach, K. (2012). Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression. American Journal of Drug and Alcohol Abuse, 38(6), 575–579. https://doi.org/10.3109/00952990.2012.696168.
Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal. Pediatrics, 129, e540–e560. https://doi.org/10.1542/peds.2011-3212.
Jones, H. E., Deppen, K., Hudak, M. L., et al. (2014). Clinical care for opioid-using pregnant and postpartum women: The role of obstetric providers. American Journal of Obstetrics and Gynecology, 210, 302–310. https://doi.org/10.1016/j.ajog.2013.10.010.
Kelly, J. J., Davis, P. G., & Henschke, P. N. (2000). The drug epidemic: Effects on newborn infants and health resource consumption at a tertiary perinatal centre. Journal of Paediatrics and Child Health, 36, 262–264. https://doi.org/10.1046/j.1440-1754.2000.00492.x.
Kelly, L. E., Rieder, M. J., Bridgman-Acker, K., Lauwers, A., Madadi, P., & Koren, G. (2012). Are infants exposed to methadone in utero at an increased risk for mortality? Journal of Population Therapeutics and Clinical Pharmacology, 19, 160–165.
Kern, J. K., West, E. Y., Grannemann, B. D., et al. (2004). Reductions in stress and depressive symptoms in mothers of substance-exposed infants, participating in a psychosocial program. Maternal and Child Health Journal, 8, 127–136. https://doi.org/10.1023/B:MACI.0000037646.01017.b9.
Kissin, W. B., Svikis, D. S., Morgan, G. D., & Haug, N. A. (2001). Characterizing pregnant drug-dependent women in treatment and their children. Journal of Substance Abuse Treatment, 21(1), 27–34. https://doi.org/10.1016/S0740-5472(01)00176-3.
Kocherlakota, P. (2014). Neonatal abstinence syndrome. Pediatrics, 134(2), e547-61. https://doi.org/10.1542/peds.2013-3524.
Krans, E., & Patrick, S. (2016). Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstetrics and Gynecology, 128(1), 4–10. https://doi.org/10.1097/AOG.0000000000001446.
Lean, R. E., Pritchard, V. E., & Woodward, L. J. (2013). Child protection and out-of-home placement experiences of preschool children born to mothers enrolled in methadone maintenance treatment during pregnancy. Children and Youth Services Review, 35(11), 1878–1885. https://doi.org/10.1016/j.childyouth.2013.09.003.
Logan, B., Brown, M. S., & Hayes, M. J. (2013). Neonatal abstinence syndrome: treatment and pediatric outcomes. Clinical Obstetrics and Gynecology, 56, 186–192. https://doi.org/10.1097/GRF.0b013e31827feea4.
Matone, M., Minkovitz, C., Quarshie, W., & Rubin, D. M. (2016). Chronic disease prevalence and discontinuation of medications among young mothers with a relationship to the child welfare system. Children and Youth Services Review, 64, 66–72. https://doi.org/10.1016/j.childyouth.2016.02.017.
Parker, J. D., & Schoendorf, K. C. (2002). Implications of cleaning gestational age data. Paediatric and Perinatal Epidemiology, 16(2), 181–187. https://doi.org/10.1046/j.1365-3016.2002.00407.x.
Patrick, S. W., Davis, M. M., Lehman, C. U., & Cooper, W. O. (2015b). Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009–2012 HHS Public Access. Journal of Perinatology, 35(8), 650–655. https://doi.org/10.1038/jp.2015.36.
Patrick, S. W., Dudley, J., Martin, P. R., et al. (2015a). Prescription opioid epidemic and infant outcomes. Pediatrics, 135(5), 842–850. https://doi.org/10.1542/peds.2014-3299.
Patrick, S. W., Kaplan, H. C., Passarella, M., Davis, M. M., & Lorch, S. A. (2014). Variation in treatment of neonatal abstinence syndrome in US Children’s Hospitals, 2004–2011. Journal of Perinatology, 34(11), 867–872. https://doi.org/10.1038/jp.2014.114.
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA, 307(18), 1934–1940. https://doi.org/10.1001/jama.2012.3951.
Pearson, R. M., Evans, J., Kounali, D., et al. (2013). Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry, 70(12), 1312–1319. https://doi.org/10.1001/jamapsychiatry.2013.2163.
Phibbs, C. S., Baker, L. C., Caughey, A. B., Danielsen, B., Schmitt, S. K., & Phibbs, R. H. (2007). Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants. The New England Journal of Medicine, 356, 2165–2175. https://doi.org/10.1056/NEJMsa065029.
Siu, A. L., & the U. S. Preventive Services Task Force (USPSTF). (2016). Screening for depression in adults: US preventive services task force recommendation statement. JAMA, 315(4), 380–387. https://doi.org/10.1001/jama.2015.18392.
Smith, M. V., Costello, D., & Yonkers, K. A. (2015). Clinical correlates of prescription opioid analgesic use in pregnancy. Maternal and Child Health Journal, 19(3), 548–556. https://doi.org/10.1007/s10995-014-1536-6.
Tolia, V. N., Patrick, S. W., Bennett, M. M., et al. (2015). Increasing incidence of the neonatal abstinence syndrome in U.S. Nnonatal ICUs. The New England Journal of Medicine, 372(22), 2118–2126. https://doi.org/10.1056/NEJMsa1500439.
Tronick, E., & Reck, C. (2009). Infants of depressed mothers. Harvard Review of Psychiatry, 17, 147–156. https://doi.org/10.1017/S0954579400005551.
Uebel, H., Wright, I. M., Burns, L., et al. (2015). Reasons for rehospitalization in children who had neonatal abstinence syndrome. Pediatrics, 136(4), e811-e820. https://doi.org/10.1542/peds.2014-2767.
Unger, A., Jung, E., Winklbaur, B., & Fischer, G. (2010). Gender issues in the pharmacotherapy of opioid-addicted women: Buprenorphine. Journal of Addictive Diseases, 29(2), 217–230. https://doi.org/10.1080/10550881003684814.
The authors gratefully acknowledge William Quarshie for his valuable assistance with data management and analyses, and the Commonwealth of Pennsylvania Office of Medical Assistance Programs, and Philadelphia Department of Public Health Vital Records Department for assistance with data acquisition. This study was supported by the Robert Wood Johnson Foundation Clinical Scholars Program at the University of Pennsylvania.
Rights and permissions
About this article
Cite this article
Faherty, L.J., Matone, M., Passarella, M. et al. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure. Matern Child Health J 22, 841–848 (2018). https://doi.org/10.1007/s10995-018-2457-6
- Neonatal abstinence syndrome
- Mental health
- Opioid use